Home

Glaxosmithkline Pharmaceuticals PE Ratio

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

PE

51.8

Last updated on: May 18, 2025

Key Highlights

  • The P/E Ratio of Glaxosmithkline Pharmaceuticals Ltd is 51.8 as of 18 May 9.00 AM .
  • The P/E Ratio of Glaxosmithkline Pharmaceuticals Ltd changed from 226.4 on March 2020 to 55.8 on March 2024 . This represents a CAGR of -24.43% over 5 years.
  • The Latest Trading Price of Glaxosmithkline Pharmaceuticals Ltd is ₹ 2827 as of 16 May 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 40.1 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 14.5. The PE Ratio of IT - Software industry is 26.2. The PE Ratio of Pharmaceuticals industry is 40.1. The PE Ratio of Retail industry is 139.8. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Glaxosmithkline Pharmaceuticals Ltd

No data available

Company Fundamentals for Glaxosmithkline Pharmaceuticals Ltd

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

Share Price

₹ 2827.6

-51.10 (-1.78%)

stock direction

Last updated on: May 16, 2025

Market Price of Glaxosmithkline Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
16 May 20252827.6
15 May 20252878.7
14 May 20252877.1
13 May 20252790.15
12 May 20252721.25
09 May 20252758.3
08 May 20252740.95
07 May 20252847.6
06 May 20252840.55
05 May 20252893.85

SWOT Analysis Of Glaxosmithkline Pharmaceuticals Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Glaxosmithkline Pharmaceuticals Ltd

Asset Value vs Market Value of Glaxosmithkline Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Glaxosmithkline Pharmaceuticals Ltd47901
Sun Pharmaceutical Industries Ltd416273
Divis Laboratories Ltd166750
Cipla Ltd121122
Torrent Pharmaceuticals Ltd110482
Mankind Pharma Ltd105963

PE Ratio of Glaxosmithkline Pharmaceuticals Ltd Explained

47901

Market cap

927

Earnings

51.8X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Glaxosmithkline Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in %

About Glaxosmithkline Pharmaceuticals Ltd

  • GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together.
  • The Company is headquartered in Mumbai and it has six branch offices, a manufacturing facility at Nashik in Maharashtra, 22 contract manufacturing organisations (CMOs) with regional and sales hubs across India.
  • The Company is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals. The Company's portfolio includes General Medicines, Vaccines and Specialty medicines that help prevent and treat disease.
  • Their prescription medicines range across therapeutic areas, such as Anti-Infectives, Dermatology, Gynaecology, Diabetes, Oncology, Cardiovascular Disease and Respiratory Diseases.

Glaxosmithkline Pharmaceuticals Ltd News Hub

Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter

Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended Ju

Read more

05 Aug 24

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarter ended Ju

Read more

03 Aug 24

GlaxoSmithKline Pharmaceuticals to conduct board meeting

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 M

Read more

19 Apr 25

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O

Read more

25 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Glaxosmithkline Pharmaceuticals Ltd

What is the current PE Ratio of Glaxosmithkline Pharmaceuticals Ltd?

The Current PE Ratio of Glaxosmithkline Pharmaceuticals Ltd is 51.84 as on 18 May 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.1 as on 18 May 2025.

What was the PE Ratio of Glaxosmithkline Pharmaceuticals Ltd last year?

The PE Ratio of Glaxosmithkline Pharmaceuticals Ltd was 36.73 last year, now the PE ratio is 51.84, showing a year-on-year growth of 41.1%.

What does the PE Ratio of Glaxosmithkline Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Glaxosmithkline Pharmaceuticals Ltd is 51.84. This ratio indicates that investors are willing to pay 51.84 times the earnings per share for each share of Glaxosmithkline Pharmaceuticals Ltd.

What is the PE Ratio Growth of Glaxosmithkline Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Glaxosmithkline Pharmaceuticals Ltd grew by 41.1% whereas, the EPS ratio grew by 14.4.

How does the PE ratio of Glaxosmithkline Pharmaceuticals Ltd compare to industry peers?

The PE ratio of Glaxosmithkline Pharmaceuticals Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Glaxosmithkline Pharmaceuticals Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Glaxosmithkline Pharmaceuticals Ltd PE Ratio.

What factors influence the PE ratio of Glaxosmithkline Pharmaceuticals Ltd PE Ratio?

The PE ratio of Glaxosmithkline Pharmaceuticals Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Glaxosmithkline Pharmaceuticals Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Glaxosmithkline Pharmaceuticals Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Glaxosmithkline Pharmaceuticals Ltd PE Ratio?

You can check the latest PE ratio of Glaxosmithkline Pharmaceuticals Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Glaxosmithkline Pharmaceuticals Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Glaxosmithkline Pharmaceuticals Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Glaxosmithkline Pharmaceuticals Ltd PE Ratio predict future stock performance?

While the Glaxosmithkline Pharmaceuticals Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions